These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22941340)

  • 1. Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma.
    Grossmann V; Bacher U; Artusi V; Kohlmann A; Nadarajah N; Kern W; Schnittger S; Haferlach T; Haferlach C
    Blood Cancer J; 2012 Aug; 2(8):e85. PubMed ID: 22941340
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
    Gralewski JH; Post GR; van Rhee F; Yuan Y
    Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
    Park JI; Strock CJ; Ball DW; Nelkin BD
    Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 Han Chinese patients with cervical carcinoma.
    Zou Y; Liu FY; Wu J; Wan L; Fang SF; Zhang ZY; Luo Y; Chen MH; Huang MZ; He M; Huang OP
    Oncol Lett; 2017 Aug; 14(2):2427-2431. PubMed ID: 28781678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.
    Xu J; Pfarr N; Endris V; Mai EK; Md Hanafiah NH; Lehners N; Penzel R; Weichert W; Ho AD; Schirmacher P; Goldschmidt H; Andrulis M; Raab MS
    Oncogenesis; 2017 May; 6(5):e337. PubMed ID: 28504689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.
    Hechtman JF; Zehir A; Yaeger R; Wang L; Middha S; Zheng T; Hyman DM; Solit D; Arcila ME; Borsu L; Shia J; Vakiani E; Saltz L; Ladanyi M
    Mol Cancer Res; 2016 Mar; 14(3):296-301. PubMed ID: 26660078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma.
    Wong KY; Yao Q; Yuan LQ; Li Z; Ma ESK; Chim CS
    Sci Rep; 2018 Sep; 8(1):13522. PubMed ID: 30201956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.
    Imperial R; Toor OM; Hussain A; Subramanian J; Masood A
    Semin Cancer Biol; 2019 Feb; 54():14-28. PubMed ID: 29175106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.
    Suzuki R; Kikuchi S; Harada T; Mimura N; Minami J; Ohguchi H; Yoshida Y; Sagawa M; Gorgun G; Cirstea D; Cottini F; Jakubikova J; Tai YT; Chauhan D; Richardson PG; Munshi N; Ando K; Utsugi T; Hideshima T; Anderson KC
    PLoS One; 2015; 10(12):e0143847. PubMed ID: 26630652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade.
    Avruch J; Khokhlatchev A; Kyriakis JM; Luo Z; Tzivion G; Vavvas D; Zhang XF
    Recent Prog Horm Res; 2001; 56():127-55. PubMed ID: 11237210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
    Nazarian R; Shi H; Wang Q; Kong X; Koya RC; Lee H; Chen Z; Lee MK; Attar N; Sazegar H; Chodon T; Nelson SF; McArthur G; Sosman JA; Ribas A; Lo RS
    Nature; 2010 Dec; 468(7326):973-7. PubMed ID: 21107323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation and Ras activation is required for hydrogen peroxide-mediated Raf-1 kinase activation.
    Ahn JH; Lee M
    Mol Cell Biochem; 2008 Oct; 317(1-2):121-9. PubMed ID: 18553175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of RAF-1 through Ras and protein kinase Calpha mediates 1alpha,25(OH)2-vitamin D3 regulation of the mitogen-activated protein kinase pathway in muscle cells.
    Buitrago CG; Pardo VG; de Boland AR; Boland R
    J Biol Chem; 2003 Jan; 278(4):2199-205. PubMed ID: 12417593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Raf as a result of recruitment to the plasma membrane.
    Stokoe D; Macdonald SG; Cadwallader K; Symons M; Hancock JF
    Science; 1994 Jun; 264(5164):1463-7. PubMed ID: 7811320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
    Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
    Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
    Steelman LS; Franklin RA; Abrams SL; Chappell W; Kempf CR; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo P; Ruvolo V; Evangelisti C; Martelli AM; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1080-94. PubMed ID: 21494257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression.
    Conrad KE; Oberwetter JM; Vaillancourt R; Johnson GL; Gutierrez-Hartmann A
    Mol Cell Biol; 1994 Mar; 14(3):1553-65. PubMed ID: 8114693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.